123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction by Cornelissen, B, Remaut, K, Kersemans, V, Oltenfreiter, R, Burvenich, I, Slegers, G

Synthesis and assessment of [11C]acetylhomotaurine as an imaging agent for the study of the pharmacodynamic properties of acamprosate by positron emission tomography. by Courtyn, J, Cornelissen, B, Oltenfreiter, R, Vandecapelle, M, Slegers, G, Strijckmans, K

In vitro and in vivo evaluation of [123I]-VEGF165 as a potential tumor marker. by Cornelissen, B, Oltenfreiter, R, Kersemans, V, Staelens, L, Frankenne, F, Foidart, J, Slegers, G

Radiosynthesis and in vivo evaluation of 123I-rTIMP-2 as potential SPECT tumour imaging agent by Oltenfreiter, R, Staelens, L, Burvenich, I, Cornelissen, B, Frankenne, F, Foidart, J, Slegers, G

Comparison between 1 T MRI and non-MRI based volumetry in inoculated tumours in mice. by Cornelissen, B, Kersemans, V, Jans, L, Staelens, L, Oltenfreiter, R, Thonissen, T, Achten, E, Slegers, G

Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor. by Cornelissen, B, Kersemans, V, Burvenich, I, Oltenfreiter, R, Vanderheyden, J, Boerman, O, Vandewiele, C, Slegers, G

Synthesis of [I-123]-3-(4-iodobenzyl)-1,2,3,4-tetrahydro-8-hydroxychromeno[3,4-c]pyridin-5-one, a potential dopamine D4 ligand for SPECT studies by Staelens, L, Oltenfreiter, R, Cornelissen, B, Blanckaert, P, De Vos, F, Deforce, D, Dierckx, R, Slegers, G

Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agents. by Oltenfreiter, R, Staelens, L, Kersemans, V, Cornelissen, B, Frankenne, F, Foidart, J, Van de Wiele, C, Slegers, G